# Nanopore vs Sanger Sequencing: A Mechanistic Comparison

## Introduction to Sanger and Nanopore Sequencing

DNA sequencing has undergone a remarkable evolution since the first complete genomes were assembled in the 1970s. Two technologies bookend this evolution: Sanger sequencing, the chain-termination method developed by Frederick Sanger in 1977, and nanopore sequencing, a single-molecule electrical sensing technology commercialized by Oxford Nanopore Technologies in the 2010s. Understanding the mechanistic differences between these methods is essential for selecting the appropriate tool for a given biological question.

Sanger sequencing relies on the controlled interruption of DNA polymerase activity using dideoxynucleotides (ddNTPs). The method produces a population of terminated fragments of varying lengths, which are then separated by size to reveal the sequence. It remains the gold standard for validating variants and sequencing individual PCR products, typically achieving read lengths of 400–900 bases with per-base accuracy exceeding 99.9%.

Nanopore sequencing, by contrast, threads a single DNA molecule through a protein pore embedded in a synthetic membrane. As the DNA passes through the pore, it modulates an ionic current in a characteristic, sequence-dependent manner. The current trace is decoded computationally to yield the sequence in real time. This approach eliminates the need for amplification, fluorescent labeling, or synchronization of identical molecules, and it can produce reads exceeding 1 megabase in length.

The two methods differ fundamentally in their biochemistry, their error profiles, and their practical applications. This article provides a mechanistic comparison of Sanger and nanopore sequencing, with emphasis on the molecular processes that define each technology's capabilities and limitations.

## Mechanism of Sanger Sequencing

### Chain Termination Chemistry

Sanger sequencing exploits the substrate specificity of DNA polymerase to generate a nested set of truncated extension products. The reaction contains four standard deoxyribonucleotide triphosphates (dNTPs) at concentrations typically in the range of 100–200 µM, along with a small proportion of fluorescently labeled dideoxyribonucleotide triphosphates (ddNTPs), usually at 1–5% of the dNTP concentration.

DNA polymerase incorporates ddNTPs into the growing strand with high efficiency because the dideoxy sugar lacks both the 2′ and 3′ hydroxyl groups. Once a ddNTP is incorporated, the polymerase cannot form the next phosphodiester bond because the 3′ hydroxyl required for nucleophilic attack on the incoming nucleotide's α-phosphate is absent. The reaction therefore terminates at that position. Because ddNTP incorporation is stochastic, the reaction produces fragments ending at every possible nucleotide position along the template.

A typical Sanger reaction uses 25–35 cycles of thermal cycling, with denaturation at 95°C for 20 seconds, annealing at 50–60°C for 15 seconds, and extension at 60°C for 1–4 minutes. The reaction buffer contains Tris-HCl (pH 8.3–9.0), KCl (50 mM), MgCl₂ (1.5–2.5 mM), and a thermostable polymerase such as AmpliTaq FS or a modified T7 polymerase. The template is typically a purified PCR product at 1–10 ng per 100 bases of template length, or a plasmid at 200–500 ng per reaction.

The four ddNTPs are each labeled with a distinct fluorophore—traditionally dR110 (blue), dR6G (green), dTAMRA (yellow), and dROX (red) in the classic BigDye chemistry, though newer dyes have shifted the emission spectra. The fluorescent label is attached to the ddNTP via a linker that does not interfere with polymerase recognition. After thermal cycling, unincorporated dye terminators must be removed by ethanol precipitation or spin-column purification, because residual free dye would otherwise obscure the signal during electrophoresis.

### Capillary Electrophoresis and Detection

The terminated fragments are separated by size using capillary electrophoresis. The purified reaction products are electrokinetically injected into a thin glass capillary (50–100 µm internal diameter) filled with a sieving polymer, typically a linear polyacrylamide or polyethylene oxide matrix. An electric field of 300–400 V/cm drives the negatively charged DNA fragments through the polymer, where they are separated according to size with single-base resolution.

The separation relies on the sieving effect of the polymer matrix: smaller fragments migrate faster through the entangled polymer network, while larger fragments are retarded. Because all fragments share the same 5′ end (the sequencing primer), the fragment length corresponds directly to the position of the terminating ddNTP relative to the primer. A laser focused on a detection window near the cathode excites the fluorophores as the fragments pass, and a four-channel optical system records the emission spectrum for each fragment.

The resulting electropherogram displays a series of peaks, each corresponding to a specific nucleotide at a specific position. Base calling software assigns the nucleotide based on the fluorescence color and the peak spacing. Modern instruments such as the Applied Biosystems 3730xl can resolve fragments up to 900–1000 bases in a single run, though the first 20–40 bases after the primer are often unreliable due to unincorporated dye terminators and primer peaks. The practical read length is typically 400–700 bases with high confidence.

The key limitation of Sanger sequencing is that each reaction produces a single sequence from a single template population. If the template contains a mixture of alleles (e.g., a heterozygous variant), the electropherogram will show overlapping peaks at the variant position, which can be called as a mixed base but complicates quantitative interpretation. The method is also inherently limited to sequencing one amplicon at a time, making it unsuitable for genome-scale projects. For a detailed protocol, see [Sanger Sequencing Protocol](/knowledge/molecular-biology/sanger-sequencing-protocol).

## Mechanism of Nanopore Sequencing

### Nanopore and Ionic Current

Nanopore sequencing is a fundamentally different approach that measures the electrical conductance of a single DNA molecule as it passes through a protein pore. The core component is a [transmembrane protein](/blog/guides/transmembrane-protein) pore, most commonly the CsgG-derived pore used in Oxford Nanopore's R9 and R10 chemistries, embedded in an electrically resistant polymer membrane. The membrane separates two chambers filled with ionic buffer, typically 150–300 mM KCl in Tris buffer (pH 7.5–8.0).

A voltage of 100–180 mV is applied across the membrane, driving a stable ionic current of approximately 100–300 pA through the open pore. The magnitude of this current depends on the pore geometry and the ionic composition of the buffer. When a DNA molecule is captured by the pore, it partially occludes the channel, reducing the ionic current in a manner that depends on the specific nucleotides occupying the narrowest constriction of the pore.

The motor protein, a helicase or polymerase fused to the pore, controls DNA translocation. The enzyme unwinds the double-stranded DNA and feeds the single strand through the pore in a ratcheted, stepwise manner, typically at a rate of 300–500 bases per second. Each nucleotide, or more precisely each combination of 4–5 consecutive nucleotides (a k-mer), produces a characteristic current level. The current is sampled at high frequency (typically 4–8 kHz) by an application-specific integrated circuit (ASIC) beneath each pore.

The R9.4 pore reads a 5-mer window, meaning the current at any given moment reflects the identity of five consecutive nucleotides. The R10 pore reads a 10-mer window, providing better discrimination of homopolymer regions. The current levels are not simply additive; they depend on the three-dimensional conformation of the nucleotides within the pore constriction, including base stacking interactions and hydrogen bonding with pore residues.

### Base Calling and Real-Time Analysis

The raw current trace is a continuous waveform with plateaus corresponding to each k-mer. The transition between plateaus occurs as each nucleotide passes through the pore. Base calling converts this electrical signal into a DNA sequence using computational models.

The first generation of base callers used hidden Markov models (HMMs) trained on known sequences to assign k-mers to current levels. Modern base callers, such as Guppy and Bonito, use recurrent neural networks (RNNs) and convolutional neural networks (CNNs) that operate directly on the raw current signal. These models are trained on large datasets of known sequences with paired current traces, learning the complex mapping between electrical signal and sequence context.

The base caller also performs quality scoring, assigning a Phred-like quality score to each base based on the confidence of the model's prediction. The quality scores are calibrated such that a Q score of 20 corresponds to an estimated error rate of 1%, Q30 to 0.1%, and so on. However, the relationship between quality score and actual accuracy is less reliable for nanopore than for Sanger sequencing, particularly in homopolymer regions and GC-rich sequences.

A critical feature of nanopore sequencing is its real-time capability. Because each molecule is sequenced independently and the signal is processed as it is generated, sequence data becomes available as soon as the molecule passes through the pore. This enables adaptive sampling, where the sequencing run can be terminated or redirected based on the identity of the molecules being read. For example, in targeted sequencing, the instrument can reject reads from off-target regions in real time, enriching for regions of interest without additional sample preparation.

The sequencing process does not require amplification, as the signal from a single molecule is sufficient for detection. This eliminates PCR bias and enables direct sequencing of native DNA, including modified bases. For example, 5-methylcytosine and 6-methyladenine produce characteristic current signatures that can be detected without bisulfite conversion, a significant advantage over methods that require chemical modification (see [Bisulfite Sequencing](/knowledge/molecular-biology/bisulfite-sequencing) for comparison).

## Key Differences in Workflow and Throughput

### Sample Preparation and Amplification

Sanger sequencing requires amplification of the target region before sequencing. The typical workflow begins with PCR amplification of the region of interest using flanking primers, followed by purification of the PCR product to remove primers and dNTPs. The purified product then serves as the template for the cycle sequencing reaction, which is a second PCR-like reaction using only one primer and a mixture of dNTPs and fluorescent ddNTPs. This two-step process requires approximately 4–6 hours from purified DNA to sequence-ready samples, not including the initial PCR.

The amplification step introduces several constraints. First, the target region must be amenable to PCR, meaning it must have suitable primer binding sites and be within the amplification limits of the polymerase (typically <5 kb for high-fidelity amplification). Second, PCR errors are incorporated into the final sequence, though the error rate of high-fidelity polymerases (approximately 1 error per 10⁵–10⁶ bases) is generally negligible for single-molecule variant calling. Third, the PCR product must be a single, homogeneous species; if the template contains multiple alleles or the PCR produces non-specific products, the resulting electropherogram will be uninterpretable.

Nanopore sequencing has minimal sample preparation requirements. For whole-genome sequencing, high-molecular-weight DNA is extracted and fragmented to the desired size (typically 10–50 kb for standard runs, or up to 200 kb with specialized protocols). The DNA is then end-repaired and ligated to adapters that contain the motor protein binding site and a tether sequence that concentrates the DNA at the pore surface. The library preparation can be completed in 30–60 minutes, and no amplification is required.

The absence of amplification is a major advantage for certain applications. It preserves the original DNA modifications, avoids GC bias introduced by PCR, and allows sequencing of molecules that are difficult to amplify, such as highly repetitive regions or sequences with extreme base composition. However, the input DNA requirement is higher than for PCR-based methods: typical nanopore libraries require 1–5 µg of high-molecular-weight DNA for whole-genome sequencing, though lower-input protocols exist for targeted applications. For a comprehensive overview of library construction, see __MASK_3__.

### Read Length and Throughput

The read length difference between Sanger and nanopore sequencing is one of the most striking contrasts. Sanger sequencing produces reads of 400–900 bases, limited by the resolution of capillary electrophoresis and the processivity of the polymerase during cycle sequencing. Fragments longer than approximately 1 kb cannot be resolved with single-base accuracy, and the signal intensity decreases with increasing fragment length due to unequal incorporation of ddNTPs.

Nanopore sequencing has no inherent read length limit. The read length is determined by the length of the DNA molecule loaded into the pore and the processivity of the motor enzyme. Reads exceeding 2 megabases have been demonstrated, and the median read length in a typical whole-genome run is 10–50 kb. This long-read capability is transformative for genome assembly, as it allows reads to span repetitive elements, structural variants, and other complex regions that are intractable with short reads.

Throughput is another major differentiator. A single Sanger capillary instrument (e.g., the 3730xl with 96 capillaries) can produce approximately 96 sequences per run, with each run taking 2–3 hours. This translates to roughly 1,000–2,000 sequences per day per instrument, or approximately 1–2 megabases of sequence data per day.

A single nanopore flow cell (e.g., the MinION R10.4.1) contains 512 channels, each with an independent pore, and can produce 10–30 gigabases of sequence data in a 72-hour run. The PromethION instrument, with 24 or 48 flow cells, can produce 5–15 terabases per run. This represents a 10⁶–10⁷-fold increase in throughput per instrument compared to Sanger sequencing. The comparison is summarized in Table 1.

| Parameter | Sanger Sequencing | Nanopore Sequencing |
|-----------|-------------------|---------------------|
| Read length | 400–900 bp | 10 kb–2 Mb (median 10–50 kb) |
| Throughput per run | 1–2 Mb (96-capillary instrument) | 10–30 Gb (MinION), 5–15 Tb (PromethION) |
| Amplification required | Yes (PCR) | No |
| Detection method | Fluorescence | Ionic current |
| Per-base accuracy | >99.9% | 95–99% (R10.4.1) |
| Primary error type | Substitutions (rare) | Indels, especially in homopolymers |
| Time to result | 4–6 hours | Real-time (minutes to hours) |
| Cost per instrument | $100K–$500K | $1K (MinION) to $500K+ (PromethION) |
| Cost per megabase | $100–$500 | $1–$10 |

## Accuracy and Error Profiles

### Sanger Accuracy

Sanger sequencing is considered the gold standard for accuracy, with per-base accuracy exceeding 99.9% in high-quality reads. The accuracy is achieved through the population averaging inherent in the method: each base is called from the fluorescence signal of millions of identical molecules, so stochastic errors in individual polymerase reactions are averaged out.

The error modes in Sanger sequencing are well characterized. The most common errors are substitutions, which occur at a rate of approximately 1 in 1,000 bases. These errors typically arise from:

- **Dye terminator incorporation bias**: The polymerase may incorporate a ddNTP at a position where the corresponding dNTP should be added, producing a truncated fragment at the wrong position.
- **Template secondary structure**: GC-rich regions can form secondary structures that cause the polymerase to pause or stall, producing peaks with reduced intensity or spurious peaks.
- **Compressions**: Regions of dyad symmetry can cause the single-stranded DNA to fold back on itself during electrophoresis, causing fragments of different lengths to migrate at the same rate and producing overlapping peaks.

The quality of Sanger reads degrades with increasing read length. The first 20–40 bases after the primer are often unreliable due to unincorporated dye terminators and primer peaks. The quality then improves to a plateau (Q20–Q40) for the next 300–600 bases, before declining as the polymerase processivity decreases and the electrophoretic resolution worsens.

Sanger sequencing is particularly reliable for detecting single-nucleotide variants (SNVs) in diploid samples. A heterozygous variant produces two peaks of roughly equal height at the variant position, which can be detected with high confidence. However, the method is less reliable for quantifying allele frequencies, as the peak height ratio can be affected by differential amplification and dye incorporation.

### Nanopore Error Modes

Nanopore sequencing has a different and more complex error profile. The per-base accuracy of current R10.4.1 chemistry is approximately 95–99% for raw reads, with consensus accuracy exceeding 99.9% when multiple reads cover the same position. The errors are predominantly insertions and deletions (indels), rather than substitutions.

The primary error modes in nanopore sequencing are:

- **Homopolymer errors**: Regions of consecutive identical bases (e.g., AAAA) are difficult to resolve because the current level changes only slightly as the homopolymer length changes. The R9 pore, which reads a 5-mer window, has particular difficulty with homopolymers longer than 5–6 bases. The R10 pore, with its 10-mer window, improves homopolymer resolution but still struggles with runs longer than 10–15 bases.
- **Motor protein stuttering**: The helicase motor can occasionally pause or slip, causing the DNA to move backward or forward by one or more bases. This produces insertion or deletion errors in the base-called sequence.
- **Base calling uncertainty**: The neural network base caller assigns probabilities to each base, and errors occur when the model is uncertain. This is particularly common in regions with unusual current signatures, such as methylated bases or damaged DNA.
- **Speed variation**: The translocation rate of the motor protein is not perfectly uniform, and variations in speed can cause the base caller to misassign the number of bases between current transitions.

The error profile has important implications for downstream analysis. Indel errors are particularly problematic for variant calling, as they can create false frameshift mutations in coding regions. However, the errors are largely random, meaning that high-depth coverage can overcome them through consensus. For example, 30× coverage with raw accuracy of 95% yields a consensus accuracy of greater than 99.9% for SNVs, though indels remain more challenging.

The accuracy of nanopore sequencing has improved substantially with each chemistry release. The R9.4 chemistry achieved approximately 90–95% raw accuracy, while the R10.4.1 chemistry with the latest base callers achieves 95–99%. For a detailed analysis of current accuracy metrics, see [Oxford Nanopore Sequencing Accuracy](/knowledge/molecular-biology/oxford-nanopore-sequencing-accuracy).

## Cost and Scalability Considerations

### Per-Sample vs Per-Genome Costs

The cost structure of Sanger and nanopore sequencing differs fundamentally. Sanger sequencing has a high per-sample cost but low upfront investment. A single Sanger reaction costs approximately $3–$10 when performed in a core facility, including the PCR amplification, cycle sequencing, and capillary electrophoresis. This cost is relatively insensitive to the read length, meaning that sequencing a 100-base fragment costs roughly the same as sequencing a 700-base fragment.

For a typical application—validating a single variant or sequencing a single PCR product—Sanger sequencing costs $10–$50 per sample, including the initial PCR. This is cost-effective for projects involving fewer than 100 samples. However, the cost scales linearly with the number of samples, and the per-base cost is high: approximately $0.01–$0.10 per base, depending on the read length.

Nanopore sequencing has a different cost profile. The MinION instrument costs approximately $1,000, making it accessible to individual laboratories. Each flow cell costs $500–$900 and produces 10–30 Gb of data, yielding a cost of approximately $0.02–$0.09 per megabase. The PromethION flow cells cost $1,000–$2,000 each and produce 100–300 Gb, reducing the cost to $0.005–$0.02 per megabase.

However, the cost per sample depends heavily on the level of multiplexing. For a single sample, the cost of a MinION flow cell is $500–$900, which is far more expensive than a single Sanger reaction. The cost advantage of nanopore emerges only when the flow cell is fully utilized, either through multiplexing many samples or through whole-genome sequencing. For example, a single MinION flow cell can sequence 24–48 barcoded bacterial genomes in a single run, bringing the cost per genome to $20–$40.

### Scalability for Large Projects

Sanger sequencing does not scale efficiently. The throughput of a single instrument is limited to approximately 1–2 Mb per day, and scaling requires purchasing additional instruments or outsourcing to large core facilities. The largest Sanger sequencing projects, such as [the Human Genome Project](/knowledge/bioinformatics/the-human-genome-project-computational-triumphs), required hundreds of instruments running in parallel for years. This limitation makes Sanger sequencing impractical for whole-genome sequencing or large-scale population studies.

Nanopore sequencing scales more flexibly. The MinION is designed for individual users and small projects, while the PromethION provides production-scale throughput. The modular nature of the technology means that users can scale from a single flow cell to dozens of flow cells without changing the fundamental workflow. The real-time data acquisition also enables adaptive scaling: if a run produces insufficient coverage, additional flow cells can be added incrementally.

The scalability of nanopore sequencing is particularly advantageous for projects that require long reads or real-time analysis. For example, a [clinical microbiology](/knowledge/diagnostics/microbiology/clinical-microbiology-from-specimen-collection-to-pathogen-identification) laboratory can use a MinION to sequence a bacterial isolate in real time, identifying the species and antimicrobial resistance genes within 2–6 hours of receiving the sample. This is not possible with Sanger sequencing, which requires multiple rounds of PCR and electrophoresis.

## Applications: Where Each Method Excels

### Sanger in Clinical Diagnostics

Sanger sequencing remains the method of choice for clinical variant validation and small-scale diagnostic testing. Its high accuracy and well-characterized error profile make it ideal for confirming variants identified by next-generation sequencing (NGS) or for testing single genes with known pathogenic variants.

Typical clinical applications include:

- **Confirmation of NGS variants**: Variants identified by NGS are routinely confirmed by Sanger sequencing before being reported to patients, particularly when the variant is novel or has clinical implications.
- **Single-gene testing**: For disorders caused by variants in a single gene (e.g., cystic fibrosis, sickle cell disease, Huntington disease), Sanger sequencing of the relevant exons is often the most cost-effective approach.
- **Fragment analysis**: Sanger instruments can also perform fragment analysis, which is used for microsatellite instability testing, trinucleotide repeat sizing, and other applications that require precise size determination.
- **Somatic mutation testing**: In oncology, Sanger sequencing is used to detect somatic mutations in specific genes (e.g., KRAS, EGFR, BRAF) in tumor samples, guiding treatment decisions.

The regulatory environment favors Sanger sequencing for clinical applications. The method has a long history of use in diagnostic laboratories, and its accuracy and reproducibility are well documented. The [Sanger Sequencing Method](/knowledge/molecular-biology/sanger-sequencing-method) is widely taught in clinical [laboratory training](/knowledge/diagnostics/molecular/laboratory-training) programs, and the interpretation of electropherograms is a standard skill for molecular diagnosticians.

### Nanopore in De Novo Assembly and Metagenomics

Nanopore sequencing excels in applications that require long reads, real-time analysis, or direct detection of base modifications. The most prominent applications are:

- **De novo genome assembly**: The long reads produced by nanopore sequencing can span repetitive elements and structural variants, enabling the assembly of complete genomes without the scaffolding challenges that plague short-read assemblies. The combination of nanopore long reads with short-read polishing (e.g., Illumina) produces reference-quality assemblies for bacteria, fungi, and increasingly for larger genomes.
- **Structural variant detection**: The long reads allow structural variants (deletions, insertions, inversions, duplications) to be detected with high sensitivity, as the reads span the breakpoints. This is particularly important for clinical genetics, where structural variants are a major cause of disease.
- **Metagenomics**: Nanopore sequencing can sequence DNA directly from environmental or clinical samples without amplification, providing a real-time view of the microbial community. The long reads allow species-level identification and the assembly of complete genomes from complex communities.
- **Epigenetics**: The direct detection of base modifications (5-methylcytosine, 6-methyladenine, and others) from the raw current signal enables epigenetic profiling without bisulfite conversion, preserving the original DNA and avoiding the degradation and bias associated with chemical treatment.
- **Real-time surveillance**: The portability of the MinION makes it suitable for field applications, including infectious disease surveillance, environmental monitoring, and point-of-care diagnostics. During the Ebola and Zika outbreaks, nanopore sequencing was used to track viral evolution in real time.

The real-time capability of nanopore sequencing is particularly valuable in [clinical microbiology](/knowledge/diagnostics/microbiology/clinical-microbiology-from-specimen-collection-to-pathogen-identification). A bacterial isolate can be sequenced directly from a colony, and the species and antimicrobial resistance profile can be determined within 2–6 hours. This is a significant improvement over traditional culture-based methods, which require 24–48 hours.

## Common Pitfalls and How to Avoid Them

### Choosing the Right Method

The choice between Sanger and nanopore sequencing depends on the specific requirements of the experiment. Common pitfalls in method selection include:

**Using Sanger for large-scale projects**: Sanger sequencing is not suitable for whole-genome sequencing, RNA-seq, or any application requiring more than a few hundred samples. Attempting to scale Sanger sequencing to these applications results in prohibitive cost and time. For large-scale projects, use nanopore sequencing or short-read NGS platforms (see [Sanger Sequencing vs NGS](/knowledge/molecular-biology/sanger-sequencing-vs-ngs) for a broader comparison).

**Using nanopore for single-variant validation**: Nanopore sequencing is overkill for confirming a single variant in a single sample. The cost of a flow cell far exceeds the cost of a Sanger reaction, and the lower raw accuracy of nanopore sequencing makes it less reliable for detecting a single variant at low coverage. For single-variant validation, Sanger sequencing is the appropriate choice.

**Ignoring the error profile**: The error profiles of the two methods have different implications. Sanger errors are primarily substitutions, which are easy to detect and correct. Nanopore errors are primarily indels, which are more problematic for variant calling. If the application requires high accuracy for indels (e.g., detecting frameshift mutations), Sanger sequencing or high-depth nanopore sequencing with consensus calling is necessary.

### Data Interpretation Pitfalls

**Sanger electropherogram artifacts**: Common artifacts include dye blobs (broad peaks at the beginning of the trace), primer peaks (sharp peaks at the start), and secondary structure compressions. These can be minimized by using purified primers, optimizing the annealing temperature, and using specialized polymerases that can read through GC-rich regions.

**Heterozygous variant calling in Sanger**: In diploid samples, a heterozygous variant produces two peaks of roughly equal height. However, the peak height ratio can vary depending on the position of the variant and the dye used. If the variant is near the beginning or end of the read, the peaks may be difficult to distinguish from noise. Confirm heterozygous variants by sequencing both strands.

**Nanopore homopolymer errors**: Homopolymer regions are the most common source of errors in nanopore sequencing. If the application requires accurate homopolymer length determination (e.g., for microsatellite analysis), use the R10 pore chemistry and high-depth coverage. Alternatively, use a hybrid approach with short-read polishing.

**Base modification misinterpretation**: The current signal from modified bases can be misinterpreted as sequence errors by standard base callers. If the sample is expected to contain modified bases (e.g., from a clinical isolate or an environmental sample), use a base caller that is trained to detect modifications, or compare the current signal to an unmodified control.

**Coverage bias**: Nanopore sequencing can have coverage bias due to the preferential loss of short or damaged DNA molecules during library preparation. This can lead to underrepresentation of certain genomic regions. Minimize this by using high-molecular-weight DNA, gentle handling, and appropriate size selection. For a detailed discussion of coverage considerations, see [Sequencing Coverage](/knowledge/molecular-biology/sequencing-coverage).

## Frequently Asked Questions

### What is the main difference between Sanger and nanopore sequencing?

The main difference lies in the detection mechanism. Sanger sequencing uses chain termination with fluorescently labeled dideoxynucleotides, followed by capillary electrophoresis to separate the terminated fragments by size. The sequence is read from the fluorescence signal of the separated fragments. Nanopore sequencing threads a single DNA molecule through a protein pore and measures the modulation of ionic current as the nucleotides pass through. The sequence is decoded from the current trace in real time. Sanger sequencing requires amplification and produces reads of 400–900 bases, while nanopore sequencing is amplification-free and produces reads that can exceed 1 megabase.

### Which is more accurate: Sanger or nanopore sequencing?

Sanger sequencing has higher per-base accuracy, typically exceeding 99.9%, compared to 95–99% for nanopore raw reads. However, nanopore consensus accuracy can exceed 99.9% when multiple reads cover the same position. The error types also differ: Sanger errors are primarily substitutions, while nanopore errors are primarily insertions and deletions, particularly in homopolymer regions.

### Can nanopore sequencing replace Sanger sequencing?

Nanopore sequencing cannot fully replace Sanger sequencing for all applications. Sanger remains the gold standard for validating single variants, sequencing individual PCR products, and clinical diagnostics where high accuracy and regulatory approval are required. Nanopore sequencing is superior for whole-genome sequencing, long-read applications, metagenomics, and real-time analysis. The two methods are complementary, and many laboratories use both.

### What are the advantages of nanopore sequencing over Sanger?

Nanopore sequencing offers several advantages: (1) long reads that can span repetitive elements and structural variants; (2) real-time data acquisition; (3) no amplification requirement, preserving base modifications and avoiding PCR bias; (4) high throughput, with a single flow cell producing 10–30 Gb; (5) portability, with the MinION being small enough for field use; and (6) direct detection of epigenetic modifications.

### What are the advantages of Sanger sequencing over nanopore?

Sanger sequencing offers: (1) higher per-base accuracy; (2) lower cost per sample for small projects; (3) well-characterized error profiles and established quality metrics; (4) regulatory approval for clinical diagnostics; (5) simpler data analysis and interpretation; and (6) established protocols and trained personnel in most molecular biology laboratories.

### How does the cost compare between Sanger and nanopore sequencing?

Sanger sequencing costs approximately $3–$10 per reaction, or $0.01–$0.10 per base. Nanopore sequencing costs $500–$900 per flow cell, producing 10–30 Gb, or $0.02–$0.09 per megabase. For small projects (fewer than 100 samples), Sanger is more cost-effective. For large projects (whole genomes, many samples), nanopore is far more cost-effective.

### What is the read length difference between Sanger and nanopore?

Sanger sequencing produces reads of 400–900 bases, with the practical limit determined by the resolution of capillary electrophoresis. Nanopore sequencing produces reads of 10–50 kb on average, with reads exceeding 2 megabases demonstrated. The long reads of nanopore sequencing enable the assembly of complete genomes and the detection of structural variants that are invisible to short-read methods.

### Which method is better for detecting structural variants?

Nanopore sequencing is far superior for detecting structural variants. The long reads span the breakpoints of deletions, insertions, inversions, and duplications, allowing precise characterization of the variant structure. Sanger sequencing, with its short reads, can only detect structural variants if the breakpoint falls within the amplified region, which is rarely the case.

## Key Takeaways

- Sanger sequencing uses chain termination with fluorescent ddNTPs and capillary electrophoresis, producing reads of 400–900 bases with >99.9% accuracy; nanopore sequencing measures ionic current through a protein pore, producing reads of 10–50 kb with 95–99% raw accuracy.
- Sanger requires PCR amplification and population averaging, while nanopore sequences single molecules without amplification, preserving base modifications and avoiding PCR bias.
- The error profiles differ fundamentally: Sanger errors are rare substitutions, while nanopore errors are predominantly indels, especially in homopolymer regions.
- Sanger is cost-effective for small projects (<100 samples) and remains the gold standard for clinical variant validation; nanopore is cost-effective for whole-genome sequencing, metagenomics, and real-time applications.
- Nanopore sequencing excels in de novo assembly, structural variant detection, and epigenetic profiling due to its long reads and direct detection of base modifications.
- The two methods are complementary, and many laboratories use both: Sanger for targeted validation and nanopore for genome-scale or long-read applications.
- When choosing between methods, consider the required read length, accuracy, throughput, cost, and the specific error modes that are acceptable for the downstream analysis.

## Further Reading

- Aftab H et al. *[Next Generation Sequencing](/blog/guides/next-generation-sequencing) Improves Diagnostic 16S rRNA Amplicon-Based Microbiota Analyses of Clinical Samples Compared to Sanger Sequencing*. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2025. [PubMed 40922658](https://doi.org/10.1111/apm.70067)
- Fu Y et al. *Clinical Performance of Nanopore Targeted Sequencing for Diagnosing Infectious Diseases*. Microbiology spectrum. 2022. [PubMed 35352939](https://doi.org/10.1128/spectrum.00270-22)
- Bakari C et al. *Development of an [Oxford nanopore sequencing](/knowledge/bioinformatics/oxford-nanopore-sequencing-from-sample-to-base-calls) technology-based [whole genome sequencing](/blog/guides/whole-genome-sequencing) method for Plasmodium falciparum to support malaria molecular surveillance*. Scientific reports. 2026. [PubMed 42209548](https://doi.org/10.1038/s41598-026-46451-8)



<div data-calculator="molecular-cloning"></div>

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)